Staged Margin Controlled Surgery At Drummoyne Surgery and Skin Cancer Clinic, we are proud to offer the most advanced surgical technique to treat skin cancers, Staged Margin Controlled Surgery or slow Mohs Micrographic Surgery (MMS). MMS was first described by Dr Frederick Mohs in 1936, a surgical trainee, when he performed chemosurgery using chemical fixation in live tissue before the tumour was removed. He was able to visualize all tumour margins under microscope after excision of the tumour. In 1985 Mohs Micrographic Surgery was officially named. Today this special surgical technique has been widely used to treat aggressive types of skin cancers or cancers in very cosmetic important areas such as the face and neck. Staged margin controlled surgery has superior cure rate of 99% of skin cancers comparing to conventional surgery of 80% - 90% and it has extremely lower 5 years recurrent rate 2% versus 20% from conventional surgery. Dr Andrew Li, a professor of surgery (China), has successfully performed a large number of cases using Slow Mohs micrographic surgical technique. By using this technique patients will be assured that 100% clearance of the tumour will be achieved once it has been treated. The other advantages this treatment provides are minimal tissue destruction and maximal conservation of cosmetic result. Dr Andrew Li was recently invited to give a presentation on staged margin controlled Surgery to the skin cancer conference of the Australasian College of Skin Cancer Medicine in Sydney March 2011.     Tumour before surgery Completely clearance Wound closure Wound healed 3 months later Indications for Straged Margin Controlled Surgery: 1) Tumour in head and neck, especially lips,nose, ears, periorbital,retroauricular sulcus, melolabial folds; 2) Large tumour >2cm; 3) Aggressive tumour, poorly defined clinical margins; 4) Recurrent tumour; 5) Positive margins after simple excision; 6) Tumours at high risk of local recurrence and/ or metastasis such as morpheaform, infiltrative, micronodular,metatypicalsubtypes of BCC, perineural BCC / SCC, keratoacanthoma, malignant melanoma, spindle cell tumours (dermatofibrosarcomaprotuberans, atypical fibroxanthoma, malignant fibrous histocytoma, leiomyosarcoma), sebaceous carcinoma, angiosarcoma, merkel cell carcinoma; |
|
|